Related Experiment Videos
[The Dutch Health Council report on haemopoietic stem cells]
1VU Medisch Centrum, afd. Hematologie, De Boelelaan 1117, 1081 HV Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|March 16, 2004
Summary
The Dutch Health Council advises on hematopoietic stem cell use, recommending public handling of umbilical cord stem cells and increased research funding. Financial constraints and strict indications limit stem cell transplantations in the Netherlands.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Context:
- The Dutch Health Council's 2003 advice on hematopoietic stem cell (HSC) use in clinical medicine.
- Stem cell transplantations (SCTs) are primarily conducted in licensed, specialized centers for hematological intensive care.
- The advent of non-myeloablative SCT has broadened treatment indications and age eligibility.
Purpose:
- To advise the Dutch government on the clinical application of HSCs.
- To address the limitations and challenges in current SCT practices in the Netherlands.
- To advocate for advancements in stem cell research and transplantation.
Summary:
- The Council recommends treating umbilical cord stem cell harvesting and handling as a public, not private, concern to establish a beneficial public bank.
- Financial instability in specialized centers and adherence to strict indications contribute to a lower volume of SCTs in the Netherlands compared to other European nations.
- The report highlights the need for enhanced support for basic research into stem cells and the immunological facets of SCT.
Impact:
- Potential for improved patient access to SCT through better financial support and broader indications.
- Advancement of stem cell research and therapeutic applications through increased funding.
- Establishment of a public umbilical cord blood stem cell bank for wider patient benefit.